Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to rise 2.22% to -9 cents per share on November 06

Q3'26

Est.

$-0.09

Q1'26

Beat

by $0.03

Q4'25

Est.

$-0.13

Q3'25

Beat

by $0.05

Q2'25

Missed

by $0.08

The last earnings report on May 13 showed earnings per share of -9 cents, beating the estimate of -11 cents. With 1.48M shares outstanding, the current market capitalization sits at 158.18M.

View a ticker or compare two or three

HUMA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HUMA